神经型钙黏附蛋白与恶性肿瘤的关系

doi:10.3877/cma.j.issn.1674-0793.2011.03.020

神经型钙黏附蛋白（N-cadherin）在上皮恶性肿瘤中表达上调，且与上皮-间质转换关系密切，N-cadherin高表达提示肿瘤的能动性和转移能力增强，在肿瘤的发生、浸润、转移、血管生成中起了重要作用。ADH-1作为N-cadherin抗体的一个全身性抗癌药，诱导靶细胞的凋亡，破坏肿瘤组织中的血管，通过破坏胞外N-cadherin间的黏附，改变N-cadherin和成纤维细胞生长因子受体（FGFR-1）间的关系，破坏FGFR-1，导致FGFR-1表达缺失，从而破坏肿瘤血管，抑制肿瘤的生长，为临床肿瘤的治疗提供了理论基础。

关键词: 神经型钙黏附蛋白, 上皮型钙黏附蛋白, 上皮-间质转换, 上皮肿瘤

The expression of N-cadherin is upregulated in epithelial malignant tumor and is associated with epithelial to mesenchymal transition.The overexpression of N-cadherin expression has been shown to promote motility and invasion. N-cadherin plays an important role in the tumorigenesis, infiltration, metastasis and angiogenesis.ADH-1 as a systemic anticancer agent can induce apoptosis of the target cells and cause tumour vascular damage,which disrupt extracellular N-cadherin adhesion, altering the association of N-cadherin and FGFR-1, and destabilized FGFR-1 to induce the expression of FGFR-1 lost, and the result was that the tumour vascular was damaged and the growth of tumor was inhibited. It providing a theoretical basis for treatment of clinical oncology.

Key words: N-cadherin, E-cadherin, EMT, epithelial tumors

1	洪士开, 陆云飞, 陈俊强, 等. Twist、E-cadherin和N-cadherin在胃癌的表达及其意义. 广东医学, 2010, 31(3): 344-346.
2	Mathias RA, Simpson RJ. Towards understanding epithelial-mesenchymal transition: a proteomics perspective. Biochim Biophys Acta, 2009, 1794(9): 1325-1331.
3	Gravdal K, Halvorsen OJ, Haukaas SA, et al. A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin Cancer Res, 2007, 13(23): 7003-7011.
4	Lou Y, Preobrazhenska O, auf dem Keller U, et al. Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis. Dev Dyn, 2008, 237(10): 2755-2768.
5	Eastham AM, Spencer H, Soncin F, et al. Epithelial-mesenchymal transition events during human embryonic stem cell differentiation. Cancer Res, 2007, 67(23): 11254-11262.
6	Kuphal S, Bosserhoff AK. Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma. Oncogene, 2006, 25(2): 248-259.
7	Li S, Jiao J, Lu Z, et al. An essential role for N-cadherin and beta-catenin for progression in tongue squamous cell carcinoma and their effect on invasion and metastasis of Tca8113 tongue cancer cells. Oncol Rep, 2009, 21(5): 1223-1233.
8	Onder TT, Gupta PB, Mani SA, et al. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res, 2008, 68(10): 3645-3654.
9	Ozaki C, Obata S, Yamanaka H, et al. The extracellular domains of E- and N-cadherin determine the scattered punctate localization in epithelial cells and the cytoplasmic domains modulate the localization. J Biochem, 2010,147(3): 415-425.
10	Park JI, Kim SW, Lyons JP, et al. Kaiso/p120-catenin and TCF/beta-catenin complexes coordinately regulate canonical Wnt gene targets. Dev Cell, 2005, 8(6): 843-854.
11	Ireton RC, Davis MA, van Hengel J, et al. A novel role for p120 catenin in E-cadherin function. J Cell Biol, 2002, 159(3): 465-476.
12	Margaret JW, Yasushi S, Masato M, et al. Cadherin switching. Cell Science, 2008, 121(6): 727-735.
13	Chetty R, Jain D, Serra S. p120 catenin reduction and cytoplasmic relocalization leads to dysregulation of E-cadherin in solid pseudopapillary tumors of the pancreas. Am J Clin Pathol, 2008, 130(1): 71-76.
14	刘云, 刘志坚, 陈江. E-cadherin、N-cadherin在大肠癌中的表达及其相关性研究. 江西医学院学报, 2006, 46(5): 29-32.
15	Jaggi M, Nazemi T, Abrahamsn NA, et al. N-cadherin switching occurs in high Gleason grade prostate cancer. Prostate, 2006, 66(2): 193-199.
16	Wallerand H, Cai Y, Wainberg ZA, et al. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines. Urol Oncol, 2010, 28(2): 180-188.
17	Kuphal S, Bosserhoff AK. Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma. Oncogene, 2006, 25(2): 248-259.
18	Jaggi M, Nazemi T, Abrahams NA, et al. N-cadherin switching occurs in high Gleason grade prostate cancer. Prostate, 2006, 66(2): 193-199.
19	Nakao S, Platek A, Hirano S, et al. Contact-dependent promotion of cell migration by the OL-protocadherin-Nap1 interaction. J Cell Biol, 2008, 182(2): 395-410.
20	Bryan RT, Tselepis C. Cadherin switching and bladder cancer. J Urol, 2010, 184(2): 423-431.
21	祝迎锋, 吴继锋, 马伟, 等. TGF- β1、Snail、E-cadherin及N-cadherin在胃癌中的表达及意义. 中国肿瘤临床, 2007, 34(24): 1403.
22	Perotti A, Sessa C, Mancuso A, et al. Clinical and pharmacological phase I evaluation of Exherin(ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours. Ann Oncol, 2009, 20(4): 741-745.
23	Radisky DC. Epithelial-mesenchymal transition. J Cell Sci, 2005, 118(Pt 19): 4325-4326.
24	Hugo H, Ackland ML, Blick T, et al. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol, 2007, 213(2): 374-383.
25	Bambang IF, Xu S, Zhou J, et al. Overexpression of endoplasmic reticulum protein 29 regulates mesenchymal-epithelial transition and suppresses xenograft tumor growth of invasive breast cancer cells. Lab Invest, 2009, 89(11): 1229-1242.
26	Blaschuk OW, Devemy E. Cadherins as novel targets for anti-cancer therapy. Eur J Pharmacol, 2009, 625(1-3): 195-198.
27	Paik JH, Skoura A, Chae SS, et al. Sphingosine 1-phosphate receptor regulation of N-cadherin mediates vascular stabilization. Genes Dev, 2004, 18(19): 2392-2403.
28	Diamond ME, Sun L, Ottaviano AJ, et al. Differential growth factor regulation of N-cadherin expression and motility in normal and malignant oral epithelium. J Cell Sci, 2008, 121(Pt 13): 2197-2207.
29	Brabletz T, Jung A, Spaderna S, et al. Opinion: migrating cancer stem cells an integrated concept of malignant tumour progression. Nat Rev Cancer, 2005, 5(9): 744-749.
30	Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cells--perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res, 2006, 66(19): 9339-9344.
31	Berry NB, Bapat SA. Ovarian cancer plasticity and epigenomics in the acquisition of a stem2like phenotype. J Ovarian Res, 2008, 1: 8.
32	Mani SA, GuoW, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 2008, 133(4): 704-715.
33	Ishii H, IwatsukiM, Ieta K, et al. Cancer stem cells and chemoradiation resistance. Cancer Sci, 2008,99(10): 1871-1877.
34	Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours:accumulating evidence and unresolved questions. Nat Rev Cancer, 2008, 8(10): 755-768.
35	Li K, He W, Lin N, et al. Downregulation of N-cadherin expression inhibits invasiveness, arrests cell cycle and induces cell apoptosis in esophageal squamous cell carcinoma. Cancer Invest, 2010, 28(5): 479-486.
36	Li K, Wang X, He W, et al. Expression of N-cadherin in esophageal squamous cell carcinoma and silencing expression of N-cadherin using RNA interference on invasiveness of EC9706 cells. Ai Zheng, 2009, 28(1): 8-13.
37	Gwak GY, Yoon JH, Yu SJ, et al. Anti-apoptotic N-cadherin signaling and its prognostic implication in human hepatocellular carcinomas. Oncol Rep, 2006, 15(5): 1117-1123.
38	Augustine CK, Yoshimoto Y, Gupta M, et al. Targeting N-cadherin enhances antitumor activity of cytotoxic therapies in melanoma treatment. Cancer Res, 2008, 68(10): 3777-3784.
39	Mariotti A, Perotti A, Sessa C, et al. N-cadherin as a therapeutic target in cancer. Expert Opin Investig Drugs, 2007, 16(4): 451-465.
40	Xian W, Schwertfeger KL, Rosen JM. Distinct roles of fibroblast growth factor receptor 1 and 2 in regulating cell survival and epithelial-mesenchymal transition. Mol Endocrinol, 2007, 21(4): 987-1000.
41	Eswarakumar VP, Lax I, Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev, 2005, 16(2): 139-149.

[1]	刘艳艳, 谭曦, 彭雪. 妊娠合并膀胱低度恶性潜能乳头状尿路上皮肿瘤并文献复习[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(02): 212-218.
[2]	庞昆, 史振铎, 郝林, 陈波, 韩从辉. 激光共聚焦内镜技术在尿路上皮肿瘤诊断中的应用进展[J]. 中华临床医师杂志(电子版), 2020, 14(04): 296-301.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Relationship between N-cadherin and malignant tumor

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Relationship between N-cadherin and malignant tumor